Prostate Cancer: Research shows new treatment option offers improved survival

A new option for men with metastatic hormone-sensitive prostate cancer that researchers say is superior to the current standard therapy. Christopher Sweeney, MBBS explains. Research presented at #ASCO19 and published in the New England Journal of Medicine. https://www.dana-farber.org/newsroom/news-releases/2019/enzalutamide-improves-survival-for-men-with-metastatic-hormone-sensitive-prostate-cancer/

Category: News
About The Author
-

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>